Yu-Chin Wu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Yu-Chin Wu has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
- Te-Chun Hsieh
Department of Biomedical Imaging and Radiological Science, China Medical University, Taichung 404, Taiwan
36 shared publications Shung-Shung Sun
Department of Nuclear Medicine and PET Center China Medical University Hospital 404 Taichung Taiwan
32 shared publicationsKuo-Yang Yen
Department of Nuclear Medicine and PET Center China Medical University Hospital 404 Taichung Taiwan
26 shared publicationsChia-Hung Kao
18 shared publications- Chia-Hung Kao
Department of Nuclear Medicine and PET Center, China Medical University Hospital, Taichung 40402, Taiwan
17 shared publications Chih-Hsiu Wang
15 shared publications
Latest Publications
- Open Access
- 14 November 2024
- Published by China Medical University in BioMedicine
- Vol. 6 (4) , 2
Treating hepatocellular carcinoma with 90Y-bearing microspheres: a review
By Te-Chun Hsieh, Yu-Chin Wu, Shung-Shung Sun, et al., Published on
- 14 November 2024
- Published by China Medical University in BioMedicine
- Vol. 6 (4) , 2
Open AccessTreating hepatocellular carcinoma with 90Y-bearing microspheres: a review
By Te-Chun Hsieh, Yu-Chin Wu, Shung-Shung Sun, et al., Published on
- Open Access
- 6 December 2016
- Published by China Medical University in BioMedicine
- Vol. 6 (4) , 1-7
Treating hepatocellular carcinoma with 90Y-bearing microspheres: a review
Hepatocellular carcinoma (HCC) is a disease usually diagnosed in its advanced-stage, and is frequently not amenable to curative surgical treatment. Also, HCC is resistant to chemotherapy and less vulnerable to radiation therapy compared to normal hepatic parenchyma. Both of these facts render the efficacy of adjuvant and palliative treatments problematic. Selective internal radiation therapy (SIRT) with 90Y-bearing microspheres is characterized by preferentially delivering substantially high doses of radiation to a liver tumor dose simultaneously limiting the damage to its non-tumorous cells, providing an opportunity for effective local tumor control and even tumor regression therapy. The current article reviews the specific characters, dosimetry, possible applications, and special considerations toward the pre-existing radiation therapy of 90Y microsphere SIRT in treating HCC.
- 6 December 2016
- Published by China Medical University in BioMedicine
- Vol. 6 (4) , 1-7
Open AccessTreating hepatocellular carcinoma with 90Y-bearing microspheres: a review
Hepatocellular carcinoma (HCC) is a disease usually diagnosed in its advanced-stage, and is frequently not amenable to curative surgical treatment. Also, HCC is resistant to chemotherapy and less vulnerable to radiation therapy compared to normal hepatic parenchyma. Both of these facts render the efficacy of adjuvant and palliative treatments problematic. Selective internal radiation therapy (SIRT) with 90Y-bearing microspheres is characterized by preferentially delivering substantially high doses of radiation to a liver tumor dose simultaneously limiting the damage to its non-tumorous cells, providing an opportunity for effective local tumor control and even tumor regression therapy. The current article reviews the specific characters, dosimetry, possible applications, and special considerations toward the pre-existing radiation therapy of 90Y microsphere SIRT in treating HCC.
- 1 June 2016
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 41 (6) , 466-468
A Mimic of Intra-abdominal Malignancy
Urachal remnant anomalies are rare, and vesicourachal diverticulum is the most uncommon subtype of these anomalies. We present such a rare case of vesicourachal diverticulum that is incidentally discovered during the staging surveillance of a known esophageal cancer with F-FDG PET/CT. The physiological urinary excretion of radiopharmaceutical in the vesicourachal diverticulum mimics intra-abdominal malignancy, which resolves spontaneously in the follow-up FDG PET/CT.
- 1 June 2016
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 41 (6) , 466-468
A Mimic of Intra-abdominal Malignancy
Urachal remnant anomalies are rare, and vesicourachal diverticulum is the most uncommon subtype of these anomalies. We present such a rare case of vesicourachal diverticulum that is incidentally discovered during the staging surveillance of a known esophageal cancer with F-FDG PET/CT. The physiological urinary excretion of radiopharmaceutical in the vesicourachal diverticulum mimics intra-abdominal malignancy, which resolves spontaneously in the follow-up FDG PET/CT.
- 1 January 2016
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 41 (1) , 86-87
Asymptomatic Solitary Metastasis to the Testis From Prostate Carcinoma Detected by FDG PET/CT
Testicular metastases, despite their proximity, from prostate adenocarcinoma are rare and usually found along with bone or other visceral metastases. We herein present a case with recurrent disease of prostate adenocarcinoma as solitary testicular metastasis detected by 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT).
- 1 January 2016
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 41 (1) , 86-87
Asymptomatic Solitary Metastasis to the Testis From Prostate Carcinoma Detected by FDG PET/CT
Testicular metastases, despite their proximity, from prostate adenocarcinoma are rare and usually found along with bone or other visceral metastases. We herein present a case with recurrent disease of prostate adenocarcinoma as solitary testicular metastasis detected by 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT).
- 1 September 2014
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 39 (9) , e398-e401
Pituitary Macroadenoma on 99mTc-TRODAT-1 Brain SPECT
Dopamine transporter (DAT) radiopharmaceuticals are capable of binding to the DAT with high selectivity, especially in the corpora striata, and have been widely used to evaluate parkinsonian disorder. However, only a few reports have mentioned about the extrastriatal pathologic DAT uptake. Herein we present an interesting case about the incidental discovery of pituitary macroadenoma with intense uptake of 99mTc-TRODAT-1.
- 1 September 2014
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 39 (9) , e398-e401
Pituitary Macroadenoma on 99mTc-TRODAT-1 Brain SPECT
Dopamine transporter (DAT) radiopharmaceuticals are capable of binding to the DAT with high selectivity, especially in the corpora striata, and have been widely used to evaluate parkinsonian disorder. However, only a few reports have mentioned about the extrastriatal pathologic DAT uptake. Herein we present an interesting case about the incidental discovery of pituitary macroadenoma with intense uptake of 99mTc-TRODAT-1.
- 1 January 2014
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 39 (1) , 99-101
Huge Primary Soft Tissue Sarcoma of the Breast on Bone Scan
A 54-year-old woman had a primary breast sarcoma with rapid enlargement in 3 months. The mass became so huge that it was more than 20 cm in diameter and occupied the entire right breast on presentation. Extraosseous uptake was present in this mass and demonstrated a unique picture, mimicking the posture of a racing driver who holds a helmet under the armpit, on the bone scan.
- 1 January 2014
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 39 (1) , 99-101
Huge Primary Soft Tissue Sarcoma of the Breast on Bone Scan
A 54-year-old woman had a primary breast sarcoma with rapid enlargement in 3 months. The mass became so huge that it was more than 20 cm in diameter and occupied the entire right breast on presentation. Extraosseous uptake was present in this mass and demonstrated a unique picture, mimicking the posture of a racing driver who holds a helmet under the armpit, on the bone scan.
- 1 September 2013
- Published by Elsevier in The American Journal of the Medical Sciences
- Vol. 346 (3) , 233
Perfect Timing Perfect Storm: A Chance Observation of Explosive Overt Visceral Metastases
- 1 September 2013
- Published by Elsevier in The American Journal of the Medical Sciences
- Vol. 346 (3) , 233
Perfect Timing Perfect Storm: A Chance Observation of Explosive Overt Visceral Metastases
- Open Access
- 17 July 2013
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 12 (1) , 105
Association between serum adipocyte fatty-acid binding protein concentrations, left ventricular function and myocardial perfusion abnormalities in patients with coronary artery disease
Background: Adipokines, including adipocyte fatty acid-binding protein (A-FABP), have been demonstrated to be involved in the pathogenesis of atherosclerosis. In the present study, we investigated the association of circulating A-FABP level with severity of myocardial perfusion abnormalities analyzed by Tl-201 dipyridamole single-photon emission computed tomography. Methods: A total of 170 patients with coronary artery disease (CAD) from cardiovascular clinics were enrolled in the study. Serum A-FABP levels, echocardiography, and stress myocardial perfusion imaging results were analyzed. Results: Compared with the patients with mild CAD (summed stress score [SSS] ≤ 8), those with moderate to severe CAD (SSS > 8) had significantly higher A-FABP concentrations. However, the difference was attenuated in the subgroup of patients with heart failure. In the correlation analyses, A-FABP level was correlated with age, body mass index, waist circumference, levels of creatinine, fasting glucose, high-sensitivity C-reactive protein, N-terminal pro-brain natriuretic peptide, adiponectin, and several echocardiographic parameters, including left ventricular ejection fraction. Multivariate logistic regression analysis demonstrated that the A-FABP level was not only associated with higher SSS (odds ratio, 1.30; 95% confidence interval [CI], 1.01–1.69; P = 0.048), but also an independent risk factor for heart failure (odds ratio 2.71, 95% CI, 1.23–5.94; P = 0.013). Conclusions: Serum A-FABP levels not only were associated with myocardial perfusion abnormalities and left ventricular function, but also predicted the presence of heart failure in our patients with CAD.
- 17 July 2013
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 12 (1) , 105
Open AccessAssociation between serum adipocyte fatty-acid binding protein concentrations, left ventricular function and myocardial perfusion abnormalities in patients with coronary artery disease
Background: Adipokines, including adipocyte fatty acid-binding protein (A-FABP), have been demonstrated to be involved in the pathogenesis of atherosclerosis. In the present study, we investigated the association of circulating A-FABP level with severity of myocardial perfusion abnormalities analyzed by Tl-201 dipyridamole single-photon emission computed tomography. Methods: A total of 170 patients with coronary artery disease (CAD) from cardiovascular clinics were enrolled in the study. Serum A-FABP levels, echocardiography, and stress myocardial perfusion imaging results were analyzed. Results: Compared with the patients with mild CAD (summed stress score [SSS] ≤ 8), those with moderate to severe CAD (SSS > 8) had significantly higher A-FABP concentrations. However, the difference was attenuated in the subgroup of patients with heart failure. In the correlation analyses, A-FABP level was correlated with age, body mass index, waist circumference, levels of creatinine, fasting glucose, high-sensitivity C-reactive protein, N-terminal pro-brain natriuretic peptide, adiponectin, and several echocardiographic parameters, including left ventricular ejection fraction. Multivariate logistic regression analysis demonstrated that the A-FABP level was not only associated with higher SSS (odds ratio, 1.30; 95% confidence interval [CI], 1.01–1.69; P = 0.048), but also an independent risk factor for heart failure (odds ratio 2.71, 95% CI, 1.23–5.94; P = 0.013). Conclusions: Serum A-FABP levels not only were associated with myocardial perfusion abnormalities and left ventricular function, but also predicted the presence of heart failure in our patients with CAD.
- 1 July 2013
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 38 (7) , 557-559
Less May Be as Good as More
We presented a patient with abnormal focal accumulation of 67Ga in the left upper abdomen. After drinking water, we successfully identified the abnormal radioactivity that was from the stomach. Subsequent endoscopic examination did not reveal gastric pathological condition. Gastric accumulation of 67Ga may relate to pathological conditions or physiological uptake, confounding interpretation of 67Ga scintigraphy. Simple water ingestion method can rapidly identify gastric 67Ga uptake, and the shape of distended stomach can also help to differentiate pathological conditions from physiological uptake, which is especially helpful for a busy nuclear medicine department and for places where the SPECT/CT systems are not available.
- 1 July 2013
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 38 (7) , 557-559
Less May Be as Good as More
We presented a patient with abnormal focal accumulation of 67Ga in the left upper abdomen. After drinking water, we successfully identified the abnormal radioactivity that was from the stomach. Subsequent endoscopic examination did not reveal gastric pathological condition. Gastric accumulation of 67Ga may relate to pathological conditions or physiological uptake, confounding interpretation of 67Ga scintigraphy. Simple water ingestion method can rapidly identify gastric 67Ga uptake, and the shape of distended stomach can also help to differentiate pathological conditions from physiological uptake, which is especially helpful for a busy nuclear medicine department and for places where the SPECT/CT systems are not available.
- 1 February 2013
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 20 (2) , 324-325
Functional neuroimages of cortical myoclonus altered by levetiracetam in a patient with sialidosis
- 1 February 2013
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 20 (2) , 324-325
Functional neuroimages of cortical myoclonus altered by levetiracetam in a patient with sialidosis